Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ruffolo retires

This article was originally published in The Tan Sheet

Executive Summary

Robert Ruffolo, Wyeth's president of research and senior VP, will retire later this year and will be succeeded by Mikael Dohlsten. Ruffolo joined Wyeth in 2000 and was responsible for all pharmaceutical research and development for the firm, including discovery, drug safety and metabolism, chemical and pharmaceutical development, clinical research and development and research operations. Wyeth President and CEO Bernard Poussot says Ruffolo helped "position our company for future growth through robust research and development programs in oncology, women's health, vaccines, inflammation, cardiovascular and metabolic diseases and neuroscience." Dohlsten was previously executive VP within pharmaceutical research and development/medicine at Boehringer Ingelheim...





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts